IRadimed Stock

IRadimed ROCE 2024

IRadimed ROCE

0.28

Ticker

IRMD

ISIN

US46266A1097

WKN

A118V4

In 2024, IRadimed's return on capital employed (ROCE) was 0.28, a 32.22% increase from the 0.21 ROCE in the previous year.

IRadimed Aktienanalyse

What does IRadimed do?

IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling IRadimed's Return on Capital Employed (ROCE)

IRadimed's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing IRadimed's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

IRadimed's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in IRadimed’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about IRadimed stock

What is the ROCE (Return on Capital Employed) of IRadimed this year?

The ROCE of IRadimed is 0.28 undefined this year.

How has the ROCE (Return on Capital Employed) of IRadimed developed compared to the previous year?

The ROCE of IRadimed has increased by 32.22% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of IRadimed?

A high Return on Capital Employed (ROCE) indicates that IRadimed has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of IRadimed?

A low ROCE (Return on Capital Employed) can indicate that IRadimed has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from IRadimed impact the company?

An increase in the ROCE of IRadimed can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of IRadimed affect the company?

A decrease in ROCE of IRadimed can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of IRadimed?

Some factors that can affect IRadimed's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of IRadimed so important for investors?

The ROCE of IRadimed is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can IRadimed take to improve the ROCE?

To improve the ROCE, IRadimed can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does IRadimed pay?

Over the past 12 months, IRadimed paid a dividend of 1.53 USD . This corresponds to a dividend yield of about 3.17 %. For the coming 12 months, IRadimed is expected to pay a dividend of 1.54 USD.

What is the dividend yield of IRadimed?

The current dividend yield of IRadimed is 3.17 %.

When does IRadimed pay dividends?

IRadimed pays a quarterly dividend. This is distributed in the months of January, June, September, December.

How secure is the dividend of IRadimed?

IRadimed paid dividends every year for the past 5 years.

What is the dividend of IRadimed?

For the upcoming 12 months, dividends amounting to 1.54 USD are expected. This corresponds to a dividend yield of 3.18 %.

In which sector is IRadimed located?

IRadimed is assigned to the 'Health' sector.

Wann musste ich die Aktien von IRadimed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IRadimed from 11/25/2024 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did IRadimed pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of IRadimed in the year 2023?

In the year 2023, IRadimed distributed 1 USD as dividends.

In which currency does IRadimed pay out the dividend?

The dividends of IRadimed are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IRadimed

Our stock analysis for IRadimed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IRadimed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.